Tag: Montelukast cancer immunology

Asthma Medication Could Unlock New Cancer Treatments A new study has revealed that Montelukast, a drug commonly prescribed for asthma and allergies, may hold the key to tackling some of the most difficult cancers, including triple-negative breast cancer. Researchers discovered that tumors exploit a protein called CysLTR1 to manipulate immune cells known as neutrophils. Normally,…